Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elise C Hoover

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Biomedical Materials Research. Part A|January 6, 2025
Antibody/siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem-Like Behavior in Triple-Negative Breast Cancer CellsElise C Hoover, Emily S Day
Molecular Therapy. Methods & Clinical Development|July 4, 2025
Membrane-modified lipid nanoparticles for RNA deliveryChitran Roy Chowdhury, Elise C Hoover, Emily S Day
ACS Omega|December 9, 2024
Conjugation of Antibodies and siRNA Duplexes to Polymer Nanoparticles via Maleimide-Thiol ChemistryElise C Hoover, Chitran Roy Chowdhury, Olivia M Ruggiero, et al.
ACS Omega|April 1, 2024
FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast CancerElise C Hoover, Olivia M Ruggiero, Rachel N Swingler, et al.
Current Opinion in Biomedical Engineering|August 23, 2021
Antibody Nanocarriers for Cancer ManagementMegan N Dang, Elise C Hoover, Mackenzie A Scully, et al.
Molecular Pharmaceutics|July 17, 2023
Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast CancerMackenzie A Scully, Dana E Wilkins, Megan N Dang, et al.
Advanced Therapeutics|July 15, 2024
Antibody and siRNA Nanocarriers to Suppress Wnt Signaling, Tumor Growth, and Lung Metastasis in Triple-Negative Breast CancerMegan N Dang, Sejal Suri, Kejian Li, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Biomedical Materials Research. Part A|January 6, 2025
Antibody/siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem-Like Behavior in Triple-Negative Breast Cancer CellsElise C Hoover, Emily S Day
Molecular Therapy. Methods & Clinical Development|July 4, 2025
Membrane-modified lipid nanoparticles for RNA deliveryChitran Roy Chowdhury, Elise C Hoover, Emily S Day
ACS Omega|December 9, 2024
Conjugation of Antibodies and siRNA Duplexes to Polymer Nanoparticles via Maleimide-Thiol ChemistryElise C Hoover, Chitran Roy Chowdhury, Olivia M Ruggiero, et al.
ACS Omega|April 1, 2024
FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast CancerElise C Hoover, Olivia M Ruggiero, Rachel N Swingler, et al.
Current Opinion in Biomedical Engineering|August 23, 2021
Antibody Nanocarriers for Cancer ManagementMegan N Dang, Elise C Hoover, Mackenzie A Scully, et al.
Molecular Pharmaceutics|July 17, 2023
Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast CancerMackenzie A Scully, Dana E Wilkins, Megan N Dang, et al.
Advanced Therapeutics|July 15, 2024
Antibody and siRNA Nanocarriers to Suppress Wnt Signaling, Tumor Growth, and Lung Metastasis in Triple-Negative Breast CancerMegan N Dang, Sejal Suri, Kejian Li, et al.
Pageof 1